Patents Assigned to BEIJING BIONAXIN BIOTECH CO., LTD
  • Optimal selection method of gene chip probes for cancer screening
    Patent number: 11710537
    Abstract: The invention relates to an optimal selection method of gene chip probes for cancer screening. The method is characterized in that the gene chip probes capable of being used for cancer screening are obtained through three stages of constructing a point mutation site (SNV) group, constructing a candidate probe group and verifying and confirming probes on the basis of nucleic acid data of a confirmed case of a selected cancer.
    Type: Grant
    Filed: January 19, 2022
    Date of Patent: July 25, 2023
    Assignee: BEIJING BIONAXIN BIOTECH CO., LTD
    Inventors: Ziang Hua, Baoquan Liu, Tian Zhu, Meiying Zhu, Junxing Wan, Jian Zhang, Na Li